Biomatter
PrivateLast Round
Seed
Aug 5, 2024
Total Funding Raised
$7.74M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Biomatter is a synthetic biology company that has developed an AI-powered platform to design and create new proteins and enzymes for applications in medicine, agriculture, and chemical biomanufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Smart Manufacturing, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biomatter Comparables
Compare Biomatter with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zymvol Biomodeling | 86% | |
| Arzeda | 81% | |
| Cradle | 79% |
Biomatter Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 5, 2024 | ||||
| Seed | Jan 11, 2021 |
Key People
Founding team and executive leadership
Biomatter Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Metaplanet Holdings | Seed |
| Practica Capital | Seed |
| Inventure | Seed |
| 70V | Seed |
| UVC Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 71% MoM, reaching 2.2K.
- Nov 9, 2025
Monthly visitors grew 294% MoM, from 453 to 1.8K.
Biomatter Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biomatter's valuation, stock price, and market status.
Is Biomatter a public or private company?
Biomatter is a private company.
What is the current stock price of Biomatter?
Biomatter is a private company with no public stock price. No recent secondary market data is available.
How much is Biomatter worth (valuation)?
Valuation information for Biomatter is not publicly available.
Can I buy Biomatter stock?
Biomatter shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Biomatter's last funding round?
Biomatter's most recent funding round was Seed on August 5, 2024.
Who are the main investors in Biomatter?
Key investors in Biomatter include Practica Capital, Inventure, UVC Partners.
Will Biomatter IPO soon?
No public IPO plans have been announced for Biomatter.
How can I track Biomatter secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biomatter's secondary market activity and sign up for updates.